Getting rid of spider veins for good is easy with Asclera, an injection sclerotherapy medicine from Merz Aesthetics. Asclera was approved by the Food and Drug Administration (FDA) in March 2010 after being available in Europe for years, and it's now available to treat spider veins in America. This morning on Today, hosts Kathie Lee and Hoda Kotb discussed spider vein treatments, including injections like Asclera.
Asclera treats uncomplicated spider and reticular veins in the lower extremities, and has not been studied in larger varicose veins. Once injected, Asclera damages the cell lining of blood vessels, causing them to close and eventually disappear.
According to a study published in the June 2010 issue of Phlebology, experts state that Asclera (polidocanol) is a highly effective sclerotherapy treatment. The authors found that Asclera demonstrated significant efficacy over other treatment options, and patients reported greater satisfaction with polidocanol than with other treatment options. The study also showed that treatment with Asclera was safe and generally well tolerated.
"The arrival of Asclera has been highly anticipated among physicians, with very positive initial reactions and the number of pre-orders exceeding our expectations," said Dennis Condon, President of BioForm Medical, Inc., a Merz Aesthetics company. "We are proud to finally deliver the next level of cosmetic procedure performance that physicians and patients demand."
It is possible to see new spider veins form, but the veins that have been treated should not return. Following injection, there may be some slight bruising and redness at the injection site.